Life Sciences on the Rise: 2021 North American Report

PUBLIC & PRIVATE FUNDING (2020-2021)

COMPANY

DEAL TYPE

COMPLETED

TYPE

$ RAISED (MM)

Fusion Pharmaceuticals

IPO

Jun 2020

Public

$212.5

Public Investment 2nd Offering

Trillium Therapeutics

Sep 2020

Public

$98.7

Notch Therapeutics

Early Stage

Feb 2021

VC

$85.0

CorVista Health

Later Stage

Mar 2021

VC

$65.0

Dnamx

Early Stage

Mar 2021

VC

$60.0

Green Relief

Later Stage

May 2020

VC

$55.0

Deep Genomics

Later Stage

Jan 2020

VC

$40.0

Public Investment 2nd Offering

Profound Medical

Jul 2020

Public

$33.8

Mednow.ca

IPO

Mar 2021

Public

$29.3

Public Investment 2nd Offering

Medicenna Therapeutics

Apr 2020

Public

$28.4

RENT VS. VACANCY COMPARISON

$55.00

0.0% 1.0% 2.0% 3.0% 4.0% 5.0% 6.0% 7.0% 8.0% 9.0% 10.0%

NNN Rents

Vacancy Rate

$50.00

$45.00

Vacancy Rate

$40.00

$35.00

$30.00

$25.00 NNN Rent $/sf

Vacancy Rate

$20.00

Average Asking Rent $/sf

$15.00

2015

2016

2017

2018

2019

2020

Data Represents the Overall Office Market Source: Cushman & Wakefield Research

Asking Rents

Vacancy Rate

REPRESENTATIVE INVESTMENT SALE TRANSACTIONS (2019-2021)

ADDRESS

TYPE

$ MM

RBA SF

DATE

BUYER

5825 Explorer Dr

Office

$33.8

103,888

June 2020

Baylis Medical

REPRESENTATIVE LEASE TRANSACTIONS (2020)

COMPANY

ADDRESS

SIZE (SF) NEW/RENEWAL TYPE

QUARTER LANDLORD

Manufacturing Facility Medical Devices

Boston Scientific Corporation

Canada Life Insurance Co. PSP Investments/ Starlight Investments HOOPP Realty Inc

2 Paget Rd, Brampton, ON 52,213 New

Q2

Biogen Canada

3250 Bloor St West

27,458 New

Office

Q3

Ipsen Biopharmaceuticals Canada

5050 Satellite Dr

12,233 New

Office

Q4

AstraZeneca

40 King St West

6,178

New

Office

Q4

KingSett Capital

/ 47

Contributor: Juana Ross, juana.ross@cushwake.com